Structure/Function Claim Nutritive Value Debate Reopened By FDA

FDA is seeking feedback on both its current regulatory approach to dietary supplement products bearing nutritive value-based structure/function claims and the potential impact of a policy reversal on the issue.

More from Archive

More from Pink Sheet